Ocular Therapeutix (OCUL) FCF Margin: 2013-2025
Historic FCF Margin for Ocular Therapeutix (OCUL) over the last 12 years, with Sep 2025 value amounting to -389.98%.
- Ocular Therapeutix's FCF Margin fell 15239.00% to -389.98% in Q3 2025 from the same period last year, while for Sep 2025 it was -357.52%, marking a year-over-year decrease of 16344.00%. This contributed to the annual value of -213.37% for FY2024, which is 8278.00% down from last year.
- As of Q3 2025, Ocular Therapeutix's FCF Margin stood at -389.98%, which was up 7.08% from -419.67% recorded in Q2 2025.
- Over the past 5 years, Ocular Therapeutix's FCF Margin peaked at -52.99% during Q3 2023, and registered a low of -435.63% during Q1 2025.
- In the last 3 years, Ocular Therapeutix's FCF Margin had a median value of -232.00% in 2024 and averaged -239.01%.
- As far as peak fluctuations go, Ocular Therapeutix's FCF Margin spiked by 77,873bps in 2021, and later crashed by 26,513bps in 2025.
- Quarterly analysis of 5 years shows Ocular Therapeutix's FCF Margin stood at -128.24% in 2021, then crashed by 752bps to -135.76% in 2022, then plummeted by 1,905bps to -154.81% in 2023, then tumbled by 7,720bps to -232.00% in 2024, then plummeted by 15,239bps to -389.98% in 2025.
- Its FCF Margin stands at -389.98% for Q3 2025, versus -419.67% for Q2 2025 and -435.63% for Q1 2025.